Current Atherosclerosis Reports

, 16:435

Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target

  • Enrica Golia
  • Giuseppe Limongelli
  • Francesco Natale
  • Fabio Fimiani
  • Valeria Maddaloni
  • Ivana Pariggiano
  • Renatomaria Bianchi
  • Mario Crisci
  • Ludovica D’Acierno
  • Roberto Giordano
  • Gaetano Di Palma
  • Marianna Conte
  • Paolo Golino
  • Maria Giovanna Russo
  • Raffaele Calabrò
  • Paolo Calabrò
Cardiovascular Disease and Stroke (P Perrone-Filardi and S Agewall, Section Editors)

DOI: 10.1007/s11883-014-0435-z

Cite this article as:
Golia, E., Limongelli, G., Natale, F. et al. Curr Atheroscler Rep (2014) 16: 435. doi:10.1007/s11883-014-0435-z
Part of the following topical collections:
  1. Topical Collection on Cardiovascular Disease and Stroke

Abstract

Atherosclerosis represents the most common pathological substrate of coronary heart disease (CHD), and the characterization of the disease as a chronic low-grade inflammatory condition is now largely accepted. A number of mediators of inflammation have been widely studied, both as surrogate biomarkers and as causal agents, in the pathophysiological network of atherogenesis and plaque vulnerability. The epidemiological observation that biomarkers of inflammation are associated with clinical cardiovascular risk supports the theory that targeted anti-inflammatory treatment appears to be a promising strategy in reducing residual cardiovascular risk on the background of traditional medical therapy. A large number of randomized controlled trials have shown that drugs commonly used in cardiovascular disease (CVD), such as statins, may be effective in the primary and secondary prevention of cardiovascular events through an anti-inflammatory effect. Moreover, several anti-inflammatory drugs are being tested for their potential to reduce residual cardiovascular risk on the background of validated medical therapy for atherosclerotic disease. In this paper, we review relevant evidence with regard to the relationship between inflammation and CVD, from pathogenesis to therapeutic strategies.

Keywords

Atherosclerosis Inflammation Statins inflammasome IL-1 beta 

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Enrica Golia
    • 1
  • Giuseppe Limongelli
    • 1
  • Francesco Natale
    • 1
  • Fabio Fimiani
    • 1
  • Valeria Maddaloni
    • 1
  • Ivana Pariggiano
    • 1
  • Renatomaria Bianchi
    • 1
  • Mario Crisci
    • 1
  • Ludovica D’Acierno
    • 1
  • Roberto Giordano
    • 1
  • Gaetano Di Palma
    • 1
  • Marianna Conte
    • 1
  • Paolo Golino
    • 2
  • Maria Giovanna Russo
    • 1
  • Raffaele Calabrò
    • 1
  • Paolo Calabrò
    • 1
  1. 1.Division of Cardiology, Cardio-thoracic and Respiratory Sciences DepartmentSecond University of Naples, AO Dei Colli-Monaldi HospitalNaplesItaly
  2. 2.Division of Cardiology, Cardio-thoracic and Respiratory Sciences DepartmentSecond University of Naples, AO S. Anna e S. SebastianoCasertaItaly

Personalised recommendations